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Background: Gail and others developed a model (GAIL) using age-at-menarche, age-at-birth of first live child,
number of previous benign breast biopsy examinations, and number of first-degree-relatives with breast cancer as
well as baseline age-specific breast cancer risks for predicting the 5-year risk of invasive breast cancer for Caucasian
women. However, the validity of the model for projecting risk in South-East Asian women is uncertain. We
evaluated GAIL and attempted to improve its performance for Singapore women of Chinese, Malay and Indian
origins.
Methods: Data from the Singapore Breast Screening Programme (SBSP) are used. Motivated by lower breast cancer
incidence in many Asian countries, we utilised race-specific invasive breast cancer and other cause mortality rates
for Singapore women to produce GAIL-SBSP. By using risk factor information from a nested case-control study
within SBSP, alternative models incorporating fewer then additional risk factors were determined. Their accuracy
was assessed by comparing the expected cases (E) with the observed (O) by the ratio (E/O) and 95% confidence
interval (CI) and the respective concordance statistics estimated.
Results: From 28,883 women, GAIL-SBSP predicted 241.83 cases during the 5-year follow-up while 241 were
reported (E/O=1.00, CI=0.88 to 1.14). Except for women who had two or more first-degree-relatives with breast
cancer, satisfactory prediction was present in almost all risk categories. This agreement was reflected in Chinese and
Malay, but not in Indian women. We also found that a simplified model (S-GAIL-SBSP) including only age-at-
menarche, age-at-birth of first live child and number of first-degree-relatives performed similarly with associated
concordance statistics of 0.5997. Taking account of body mass index and parity did not improve the calibration of
S-GAIL-SBSP.
Conclusions: GAIL can be refined by using national race-specific invasive breast cancer rates and mortality rates for
causes other than breast cancer. A revised model containing only three variables (S-GAIL-SBSP) provides a simpler
approach for projecting absolute risk of invasive breast cancer in South-East Asia women. Nevertheless its role in
counseling the individual women regarding their risk of breast cancer remains problematical and needs to be
validated in independent data.* Correspondence: gao.fei@nhcs.com.sg
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The best-known statistical model available for predicting
an individual woman’s chance of developing breast can-
cer is that derived using information from regularly
screened Caucasian women from the USA participating
in the Breast Cancer Detection Demonstration Project
(BCDDP) [1]. This model uses age-at-menarche, age-at-
birth of first live child, number of previous benign breast
biopsy examinations, and number of first-degree-relatives
with breast cancer as well as baseline age-specific breast
cancer risks, to provide a predicted probability of invasive
or in situ breast cancer development. Subsequently, the
baseline hazard was modified using invasive breast cancer
rates from the National Cancer Institute’s Surveillance,
Epidemiology and End Results (SEER) program from
1983-7 to obtain the model we term GAIL [2].
GAIL is well calibrated among Caucasian women who
received annual screening [1-3]. Although derived from
a particular group of Caucasian women, GAIL also per-
mits projections for women with differing characteristics
including those of other ethnic groups. But, because of
the wide variation in international breast cancer rates
and the risk factors associated with breast cancer, GAIL
may not always perform well [4-7]. For example, Kaur et al
[5] concluded that GAIL only applied to their subpopula-
tion of women who had received screening mammograms
and is not readily applicable to all American-Indian and
Alaska-Native women. Similar conclusions were found for
women from the Czech Republic [6] and Italy [7].
Because breast cancer rates are higher for Caucasian
than African-American women over 40 years, and the
reverse for younger women, Gail et al [8] amended
GAIL to account for this racial difference using data
from African-American women participating in the
Women’s Contraceptive and Reproductive Experiences
(CARE) Study. Further this modified model, termed
CARE by Gail et al [8], is more parsimonious in that
age-at-birth of first live child and its interaction with
the number of affected first-degree-relatives are no
longer included. CARE fits the Women’s Health Initiative
Studies [8] data well with 350 cases observed and 323
expected but under predicts risk in African-American
women with previous breast biopsy examinations.
Breast cancer rates are increasing throughout Asia and
it is the leading cancer among Singaporean women [9],
although the incidence rate is markedly lower than that
for Caucasian women with a different etiology, particu-
larly an earlier age-of-onset. It is also likely that only a
small proportion of Asian women have received regular
mammograms based on coverage of available screening
programs. Thus, it is important to recognize limitations
of the breast cancer prediction models when counseling
women of different ethnic groups. The aim of this paper
is to examine and modify models of 5-year invasivebreast cancer risk in participants of the Singapore Breast
Screening Programme (SBSP) to account specifically for
women of Chinese, Malay and Indian origins.
Methods
Components of the Gail Models
To estimate the probability of invasive breast cancer in
women using Gail models several components for the
calculations have to be determined, the values of which
depend on the specific women concerned. If, apart from
those aged 0-19 years and greater than 85 years, the age
range is divided into 15 equal divisions of 5 years, with the
end of the age-group j indexed by τj (Table 1) then, for an
individual at age a=τj-1 within a particular relative risk, rij,
the probability of developing breast cancer by age a+5 is
given, following Gail (1989, Equation 6) [1], by
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where i refers to the binary split of the current age (AGE-
CAT=0,1) at 50 years.
In a USA context, the important risk factors, and their
category weightings, for the development of relative risk,
rij, include the current age, age-at-menarche (AGEMEN),
age-at-first-live-birth (AGEFLB) (nulliparous coded 2), num-
ber of first-degree-relatives with breast cancer (NUMREL),
and number of previous benign breast biopsies (NBIOPS),
presence of atypical hyperplasia (ATYPICAL) and inter-
action terms (AGEFLB×NUMREL and NBIOPS×AGECAT)
[1,2].
In equation (1), bj=Bj[1–AR(AGECAT)] is the baseline
age-specific composite breast cancer rate for age-group
j, Bj is the age-specific breast cancer incidence rate and
AR is the attributable risk in the broader age category
within which j falls. When developing GAIL, AR for the
USA Caucasian population was found to be approximately
constant in those less than 50 years at AR−49=0.4771, and
for older women at AR50+=0.4736.
For an individual in risk group i of age a=τj-1, the
probability of remaining breast cancer free up to the age,
τj, is estimated by S(τj)=S(τj − 1)exp(−bjrijΔ). In addition,
the age-specific hazard cj of dying of other causes is
assumed to be the same for all subjects in the age-group
j. The probability of surviving competing risks up to the
end of the age-group j, τj, is estimated by C(τj)=C(τj − 1)
exp(−cjΔ), where C(0)=1.
The Fortran program BCPTCARE of the National
Cancer Institute calculates equation (1), for given values
rij, by combining these with data providing information
on a, Bj and cj.
Table 1 Age-specific breast cancer incidence rates per 100,000 women years, Bj and competing mortality rates per 100,000 women years, cj established for
Caucasian women in the USA when developing GAIL and the comparative values for Singapore as a whole, and for the three main ethnic groups used in risk











Age J τj Bj cj Bj cj Bj cj Bj cj Bj cj
0 – 19 1 20 0 0 0.3 11.7 0.2 10.5 0.5 17.4 0.5 11.0
20 – 24 2 25 1 49.3 1.9 14.3 1.8 11.9 1.1 25.7 2.2 12.9
25 – 29 3 30 7.6 53.1 8.1 14.2 7.0 12.5 15.9 22.5 4.9 19.7
30 – 34 4 35 26.6 62.5 24.8 19.8 25.5 16.8 27.7 47.0 5.9 14.8
35 – 39 5 40 66.1 82.5 57.6 32.6 60.3 29.4 60.0 53.9 31.6 34.8
40 – 44 6 45 126.5 130.7 118.7 58.5 121.5 51.6 123.7 98.6 87.9 60.7
45 – 49 7 50 186.6 218.1 162.6 106.2 169.1 95.1 145.1 175.1 128.4 111.9
50 – 54 8 55 221.1 365.5 187.0 182.1 193.6 165.1 158.4 297.5 147.2 212.6
55 – 59 9 60 272.1 585.2 204.3 319.1 211.0 271.1 167.0 617.7 181.5 445.9
60 – 64 10 65 334.8 943.9 199.1 565.9 202.1 489.6 209.3 1093.0 157.6 853.3
65 – 69 11 70 392.3 1502.8 193.9 989.5 199.8 856.5 131.9 2040.3 219.5 1158.5
70 – 74 12 75 417.8 2383.9 166.5 1798.6 161.3 1624.3 199.1 3034.6 152.5 1932.2
75 – 79 13 80 443.9 3883.2 179.0 3285.3 180.9 3001.6 128.6 5678.6 197.2 3662.0
80 – 84 14 85 442.1 6682.8 189.8 5681.0 191.4 5388.2 188.4 8681.2 125.0 6093.8
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SBSP
SBSP recruited 29,193 female permanent residents and
citizens of Singapore, including 24,609 ethnically Chinese,
1,630 Malay and 1,434 Indian, from 01 October 1994 to
28 February 1997. Women were eligible with no previ-
ously diagnosed cancers (except non-melanoma of the
skin), no mammography within the past year or biopsy
within the last 6 months. Prior to mammography, all
attendees completed a questionnaire including demo-
graphics; reproductive and family histories; smoking; and
menopausal hormone therapy use [10,11].
Included in the risk evaluation are those who were
disease-free (including 33 in situ) at the time of breastTable 2 Breast cancer risk factors, and associated regression
Gail-based models
Risk factor Categories BCDDP
Code β Code
Main effects
AGECAT (y) <50 0 0.01081 0
≥50 1 1
AGEMEN (y) ≥14 0 0.09401 0
12–13 1 1
<12 2 2
AGEFLB (y) <20 0 0.21863 0
20–24 1 1
25–29 or nulliparous 2 2
≥30 3 3
NUMREL 0 0 0.95830 0
1 1 1
≥2 2 2
NBIOPS 0 0 0.52926 0
1 1 1
≥2 2 1
ATYPICAL No 0 0.57405* 99
Yes 1 99
BMI (kg/m2) < 23.0 – – 0
23.0 – 27.4 1
≥ 27.5 2
PARITY ≥ 3 – – 0
1 – 2 1
0 2
Interaction terms
NBIOPS x AGECAT −0.28804
AGEFLB x NUMREL −0.19081
* Given by Novotny et al (2006, Table 2) [6].cancer screening. In order to focus on incident breast
cancer, women were included only if they were followed-
up to be alive without disease (5 in situ) for the next
3 years. As the prevalent breast cancers are not included,
the study women have a lower absolute risk than the
general female population [12]. Thus the 'clock' was
started 3 years from the date of their negative screen
and, amongst these women, those who developed inva-
sive breast cancer in the following 4-8 year period are
the designated cases. Any women with in situ disease
who then developed an invasive cancer were considered
as invasive in the year of this latter diagnosis. Women
with unknown age-at-menarche or date-of-diagnosis
were excluded.coefficients (β), used in developing the alternative
GAIL-SBSP GAIL-SBSP (FULL) S-GAIL-SBSP E-GAIL-SBSP
β β (CI) β (CI) β (CI)
0.01081 0.807 – –
(–0.73 to 2.35)
0.09401 0.240 0.238 0.204
(0.05 to 0.43) (0.05 to 0.43) (0.01 to 0.39)
0.21863 0.185 0.183 0.170
(0.016 to 0.31) (0.06 to 0.31) (0.03 to 0.31)
0.95830 0.844 0.777 0.774
(–0.17 to 1.86) (0.30 to 1.26) (0.29 to 1.26)
0.52926 −15.877 – –
(–16.28 to –15.47)
– – – –
– – – 0.380
(0.22 to 0.54)
– – – 0.203
(0.03 to 0.38)
−0.28804 16.138 – –
(Not estimatable)
−0.19081 −0.059 – –
(–0.61 to 0.50)
Gao et al. BMC Cancer 2012, 12:529 Page 5 of 14
http://www.biomedcentral.com/1471-2407/12/529The study was approved by the Singhealth Institu-
tional Review Board (2008/468/B) and National Cancer
Centre Institutional Review Board (NC08-041). As this
was a large population based study, with full anonymity
of all data, direct consent from the participants is
waivered.
Nested case-control study
To study risk factors for breast cancer, a nested case-
control study was conducted within SBSP in 2006 [13].
Women who were screened-positive (including those
with in situ disease) or developed invasive breast cancer
before 2006 were defined as case patients. Control sub-
jects were selected from those who did not have a breast
cancer diagnosis at the time of study. These were matched
to cases by 5-year at age-at-entry groups and calendar year
of entry into the SBSP program and ethnicity. Data from
these women was used to build a model to project abso-
lute invasive breast cancer risk.
Follow-up and breast cancer ascertainment
Breast cancer incidence and death status for SBSP parti-
cipants were notified as either detected through SBSP or
subsequently through record linkage with the Singapore
Cancer Registry (SCR). All whose death status was not
captured were assumed alive at 1 March 2009. SCR
includes all cases of cancer occurring in citizens and per-
manent residents (population near 5 million) between
1968 and 2008. Annual invasive breast cancer cases and
annual non-breast cancer deaths are obtained from SCR
and annual population numbers from Singapore Resi-
dent Population report (2003-2007) [14]. These were
used to calculate average race-specific estimates of Bj,
and cj for the period 2003-2007 (Table 1, Singaporean).
Statistical analyses
To estimate the probability of invasive breast cancer for
a different population one can assume that all the com-
ponents necessary are already contained in GAIL. That
is, the regression coefficients, β, (Table 2, BCDDP), to-
gether with Bj and cj, remain as those specified when
formulating that model (Table 1, Caucasian women).
The calculated probabilities can be applied to an age-
specific group of interest to provide the expected number
of cases, E. This can then be compared to the actual num-
ber of cases observed, O. A ratio of E/O = 1 indicating per-
fect agreement within that age category. The corresponding






If k age categories are concerned then, under the null
hypothesis,
P
(O – E)2/E follows a χ2 distribution with
k degrees of freedom [8].
In a preliminary investigation, we noted that applying
GAIL unchanged to Singaporean women substantiallyoverestimated the number of invasive breast cancer
cases: (O=241, E=401.54, E/O=1.67). Consequently our
study aim was modified, to one investigating features of
the local population which might influence the ultimate
predictions while preserving the Gail-based modelling
approach.
Breast cancer rates and competing mortality rates are
much lower for Singaporeans of all ethnic groups than
Caucasians in those over the age of 30; particularly so in
those > 70 years (Table 1, Singaporean). To take into ac-
count such differences, which may influence the expected
value E [7,8,15], we formulated GAIL-SBSP using the
regression coefficients and AR derived from the BCDDP
cohort (Table 2) combined with the average race-
specific estimates of Bj, and cj for the period 2003-2007
for Singaporean women (Table 1).
In validating GAIL-SBSP we were unable to classify
SBSP participants with respect to either history of previ-
ous benign biopsy or atypical hyperplasia status. Conse-
quently those ever having previous benign breast biopsies
[11] were categorized as a single biopsy, and atypical
hyperplasia was categorized as unknown.
As it is known that the etiological factors for breast
cancer vary according to, for example, ethnicity and/or
geographical location of the women, the risk factors con-
cerned and/or their weightings in the established Gail
model may require some modification. To explore this,
we used subjects from the nested case-control study.
Relative odds were obtained by use of multiple logistic
regression with the same independent variables and coding
as GAIL-SBSP (Table 2). A simplified model (S-GAIL-
SBSP) with only three variables – age-at-menarche, age-at-
birth of first live child and number of first-degree-relatives
with breast cancer was identified. In contrast, in order to
explore whether adding other risk factors could predict in-
vasive breast cancer with improved accuracy, the extended
model (E-GAIL-SBSP) added ethnicity (ETHNICITY),
parity (PARITY), smoking (SMOKING), body mass index
(BMI), use of hormonal replacement therapy (HRT), use
of oral contraception (OC) and waist-to-hip ratio (WHR).
The body mass index was categorized as <23.0, 23.0–27.4
and ≥27.5 kg/m2 (coded as 0, 1 or 2) following the World
Health Organization (WHO) guideline for Asian popula-
tions [16]. To avoid missing any potentially important
predictors P<0.05 was used for statistical significance to
select variables for multivariate modeling. Finally E-
GAIL-SBSP was created by taking only those variables
with prognostic significance into the model.
Model discriminatory accuracy was measured by the
age-specific concordance statistic, using a logistic regres-
sion model of breast cancer status on the estimated
risks. Thus each model was assessed by use of the area
under the receiver operating characteristics curve (AUC)
created by computing sensitivity and specificity [17]. The
Table 3 Comparison of the expected cases (E) of invasive breast cancer predicted by each respective model, to the observed cases (O) in the Singapore Breast
Screening Programme (SBSP) cohort for each ethnic group
Age at entry, (y) No. of women followed GAIL-SBSP S-GAIL-SBSP E-GAIL-SBSP
O E E/O (CI) P E E/O (CI) P E E/O (CI) P
Overall
45–49 109 0 0.95 – 0.092 0.97 – 0.111 0.96 – 0.006
50–59 13,911 144 124.11 0.86 (0.73 to 1.01) 124.86 0.87 (0.74 to 1.02) 149.12 1.04 (0.88 to 1.22)
60–69 14,642 95 115.38 1.21 (0.99 to 1.49) 114.57 1.21 (0.99 to 1.47) 137.70 1.45 (1.19 to 1.77)
70–74 221 2 1.40 0.70 (0.18 to 2.80) 1.40 0.70 (0.17 to 2.80) 1.69 0.85 (0.21 to 3.38)
Total 28,883 241 241.83 1.00 (0.88 to 1.14) 0.957 241.80 1.00 (0.88 to 1.14) 0.959 289.47 1.20 (1.06 to 1.36) 0.004
Chinese
45–49 93 0 0.85 – 0.440 0.87 – 0.480 0.84 – 0.076
50–59 11,795 119 109.98 0.92 (0.77 to 1.11) 109.64 0.92 (0.77 to 1.10) 127.35 1.07 (0.89 to 1.28)
60–69 12,256 87 99.85 1.15 (0.93 to 1.42) 98.22 1.13 (0.91 to 1.39) 115.12 1.32 (1.07 to 1.63)
70–74 195 2 1.21 0.60 (0.15 to 2.42) 1.20 0.60 (0.15 to 2.40) 1.44 0.72 (0.18 to 2.88)
Total 24,339 208 211.88 1.02 (0.89 to 1.17) 0.790 209.93 1.01 (0.88 to 1.16) 0.894 244.75 1.18 (1.03 to 1.35) 0.019
Malay
45–49 7 0 0.05 – 0.652 0.06 – 0.591 0.05 – 0.209
50–59 711 4 4.91 1.23 (0.46 to 3.27) 5.23 1.31 (0.49 to 3.48) 7.27 1.82 (0.68 to 4.85)
60–69 889 2 5.41 2.71 (0.68 to 10.82) 5.67 2.84 (0.71 to 11.34) 7.72 3.86 (0.97 to 15.43)
70–74 12 0 0.08 – 0.08 – 0.11 –
Total 1,619 6 10.46 1.74 (0.78 to 3.88) 0.168 11.04 1.84 (0.83 to 4.09) 0.130 15.15 2.53 (1.13 to 5.62) 0.019
Indian
45–49 5 0 0.03 – <0.001 0.03 – <0.001 0.02 – 0.002
50–59 683 16 4.75 0.30 (0.18 to 0.48) 5.08 0.32 (0.19 to 0.52) 6.98 0.44 (0.27 to 0.71)
60–69 727 1 5.34 5.34 (0.75 to 37.90) 5.56 5.56 (0.78 to 39.49) 7.58 7.58 (1.07 to 53.79)
70–74 7 0 0.04 – 0.04 – 0.05 –
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average of the age-specific concordances used weights
proportional to the number of women in each age group
[18]. The variance for the average age-specific concord-
ance was the sum, over the age groups, of the weight
squared multiplied by the estimated variance of the age-
specific concordance estimate. Age-groups with no cases
are excluded from the calculations.Results
GAIL-SBSP
Of the 29,193 women in SBSP, 28,883 were available for
the 5-year risk assessment. A total of 241 invasive cases
were observed and these are categorized by ethnicity
and age-group together with the numbers predicted by
GAIL-SBSP (Table 3). In total GAIL-SBSP predicted
241.83 cases (E/O=1.00, CI=0.88 to 1.14) – suggesting
good model calibration (goodness-of-fit, P=0.957). This
satisfactory prediction was also seen within all age
groups (goodness-of-fit, P=0.092). This agreement was
reflected in Chinese and Malay, but not in the relatively
few Indian women as 17 cases were observed and only
10.16 predicted (E/O=0.60, CI=0.37 to 0.96).
In general, predictions were good amongst the various
risk categories (Table 4). However, among women who
had two or more first-degree-relatives with breast cancer,
the numbers were under predicted (E/O=0.18, CI=0.04 to
0.71) while for those with no history there was excellent
calibration (E/O=1.02, CI=0.90 to 1.16).S-GAIL-SBSP
To estimate the relative risk function, we analyzed 439 in-
vasive breast cancer cases (121 diagnosed at screening and
318 subsequently) and 1,198 controls from the nested
case-control study (Table 5). As far as possible, those risk
factors identified for GAIL were initially used to estimate
the regression coefficients which were reported in Table 2
(GAIL-SBSP (FULL)). Using the same model structure
there are some substantial differences, and a good deal
of instability when estimating the interaction terms, as
compared to those derived for GAIL. As a conse-
quence, the simplified model S-GAIL-SBSP including
only age-at-menarche, age-at-birth of first live child
and number of first-degree-relative with breast cancer
to obtain the relative risks (RR) was derived (Table 2, S-
GAIL-SBSP). The corresponding RRs for each of the
risk categories are given in Table 6 where they are com-
pared with those used in GAIL (Table 6, BCDDP).
Omitting age and number of previous benign breast biop-
sies and the interactions did not degrade the fit of the
model (P=0.359).
The differences in the RRs between the nested case-
control study and BCDDP are largest only in the groupswhere the number of first-degree-relatives with breast
cancer is two or more.
The simplified model with only three variables – age-
at-menarche, age-at-birth of first live child and number
of first-degree-relative with breast cancer utilized the
modified RRs and predicted 241.80 cases (E/O=1.00,
CI=0.88 to 1.14) (Table 3). The satisfactory prediction
was seen in all ethnic groups although among Indian
women, as was the case for GAIL-SBSP, the calibration
was not entirely consistent across all age-groups.
Again similar to GAIL-SBSP, S-GAIL-SBSP predictions
were relatively close amongst the various risk categories
(Table 4). However, the model underestimated the observed
incidence of breast cancer for women who had a biopsy
although this was not statistically significant (E/O=0.67,
CI=0.44 to 1.01) while for those without a biopsy there was
a very good calibration (E/O=1.04, CI=0.91 to 1.19).
E-GAIL-SBSP
To determine whether other risk factors could improve
S-GAIL-SBSP performance, the effects of the Gail model
risk factors were re-estimated in a multiple logistic re-
gression that used subjects from the nested case-control
study. We expanded the model by including ethnicity,
parity, smoking, BMI, use of hormonal replacement
therapy, use of oral contraception and waist-to-hip ratio
to estimate the regression coefficients (Table 5). In
addition to age-at-menarche, age-at-birth of first live
child and number of first-degree-relatives with breast
cancer, both parity and BMI were significantly associated
with the probability of invasive breast cancer.
Following Gail et al [8], the ARs necessary to convert
Singaporean age-specific invasive breast cancer rates to
baseline rates for SBSP women were calculated. In order
to match the follow-up period of the SBSP participants,
this was based on invasive cases diagnosed over 1993-
2002 [9,19] and over 2003-2007 [SCR unpublished]. Esti-
mates of AR were 0.5356 for those younger than 50
years and 0.5397 for older women. These ARs and modi-
fied RRs were used to re-evaluate equation (1) and hence
formulated E-GAIL-SBSP together with Singapore race-
specific estimates of Bj and cj (Table 1).
Overall, E-GAIL-SBSP predicted 289.47 cases (E/O=1.20;
CI=1.06 to 1.36) and so was not able to satisfactorily
capture the number of cases among the various risk cat-
egories (goodness-of-fit, P=0.004). Moreover, E-GAIL-
SBSP statistically significantly underestimated the number
of cases among women with two or more first-degree-
relatives with breast cancer (E/O=0.24, CI=0.06 to 0.97).
Comparison between the three models
In the calibration, the SBSP participants were divided
into deciles of 5-year invasive breast cancer risks pre-
dicted by GAIL-SBSP, S-GAIL-SBSP and E-GAIL-SBSP,
Table 4 Comparison of the expected cases (E) of invasive breast cancer predicted by each respective model, to the observed cases (O) in the Singapore Breast
Screening Programme (SBSP) cohort by risk factor category
Risk factors No. of women followed GAIL-SBSP S-GAIL-SBSP E-GAIL-SBSP
O E E/O (CI) P E E/O (CI) P E E/O (CI) P
AGEMEN (y)
≥14 18,652 142 148.50 1.05 (0.89 to 1.23) 0.890 139.32 0.98 (0.83 to 1.16) 0.945 165.22 1.16 (0.99 to 1.37) 0.035
12–13 9,279 89 83.81 0.94 (0.77 to 1.16) 90.61 1.02 (0.83 to 1.25) 109.59 1.23 (1.00 to 1.52)
<12 952 10 9.53 0.95 (0.51 to 1.77) 11.87 1.19 (0.64 to 2.21) 14.66 1.47 (0.79 to 2.73)
NBIOPS
0 27,176 218 222.80 1.02 (0.89 to 1.17) 0.629 226.43 1.04 (0.91 to 1.19) 0.129 271.38 1.24 (1.09 to 1.42) 0.003
1 1,707 23 19.04 0.83 (0.55 to 1.25) 15.37 0.67 (0.44 to 1.01) 18.09 0.79 (0.52 to 1.18)
NUMREL
0 28,143 225 229.50 1.02 (0.90 to 1.16) 0.045 227.71 1.01 (0.89 to 1.15) 0.109 272.98 1.21 (1.06 to 1.38) 0.004
1 729 14 11.98 0.86 (0.51 to 1.44) 13.67 0.98 (0.58 to 1.65) 16.01 1.14 (0.68 to 1.93)
≥2 11 2 0.36 0.18 (0.04 to 0.71) 0.42 0.21 (0.05 to 0.83) 0.48 0.24 (0.06 to 0.97)
AGEFLB (y)
<20 4,952 26 29.89 1.15 (0.78 to 1.69) 0.900 31.58 1.21 (0.83 to 1.78) 0.750 39.77 1.53 (1.04 to 2.25) 0.038
20–24 10,840 77 80.61 1.05 (0.84 to 1.31) 81.02 1.05 (0.84 to 1.32) 94.41 1.23 (0.98 to 1.53)
25–29 or nulliparous 9,843 97 93.48 0.96 (0.79 to 1.18) 92.61 0.95 (0.78 to 1.16) 112.39 1.16 (0.95 to 1.41)
≥30 3,248 41 37.85 0.92 (0.68 to 1.25) 36.59 0.89 (0.66 to 1.21) 42.90 1.05 (0.77 to 1.42)
BMI (kg/m2)
<23.0 10,237 68 89.31 1.31 (1.04 to 1.67) 0.018 88.34 1.30 (1.02 to 1.65) 0.028 75.94 1.12 (0.88 to 1.42) 0.026
23.0–27.4 12,225 107 101.99 0.95 (0.79 to 1.15) 102.09 0.95 (0.79 to 1.15) 124.26 1.16 (0.96 to 1.40)
≥27.5 6,411 66 50.45 0.76 (0.60 to 0.970 51.29 0.78 (0.61 to 0.99) 89.21 1.35 (1.06 to 1.72)
Parity
≥3 20,197 147 156.72 1.07 (0.91 to 1.25) 0.632 157.01 1.07 (0.91 to 1.26) 0.615 178.11 1.21 (1.03 to 1.42) 0.041
1–2 6,410 68 63.16 0.93 (0.73 to 1.18) 62.80 0.92 (0.73 to 1.17) 78.57 1.16 (0.91 to 1.47)


















Table 5 Baseline characteristics and odds ratios (OR) of invasive breast cancer in the nested case-control study
Characteristics Categories Cases (N=439) Controls (N=1,198) Adjusted OR (CI) P
AGECAT (y) < 50 2 11 1.00 (referent) 0.317
≥ 50 437 1187 2.19 (0.47 to 10.13)
AGEMEN (y) ≥ 14 246 772 1.00 (referent) 0.039
12 – 13 173 377 1.23 (1.01 to 1.49)
< 12 20 49 1.51 (1.24 to 1.83)
AGEFLB (y) < 20 56 187 1.00 (referent) 0.015
20 – 24 132 440 1.19 (1.04 to 1.37)
25 – 29 or nulliparous 185 425 1.42 (1.23 to 1.64)
≥ 30 66 144 1.69 (1.47 to 1.95)
NUMREL 0 411 1162 1.00 (referent) 0.002
1 25 36 2.15 (1.31 to 3.52)
≥ 2 3 0 4.62 (2.82 to 7.56)
NBIOPS 0 398 1119 1.00 (referent) 0.234
≥ 1 41 79 1.28 (0.85 to 1.94)
ETHNICITY Chinese 377 1051 1.00 (referent)
Malay 15 29 0.96 (0.58 to 1.59) 0.868
Indian 25 65 1.30 (0.67 to 2.50) 0.434
Others 22 53 1.02 (0.60 to 1.74) 0.936
BMI (kg/m2) < 23.0 126 476 1.00 (referent) <0.001
23.0 – 27.4 207 497 1.43 (1.22 to 1.68)
≥ 27.5 106 223 2.04 (1.73 to 2.39)
PARITY ≥ 3 263 801 1.00 (referent) 0.031
1 – 2 112 276 1.22 (1.02 to 1.46)
0 64 121 1.49 (1.24 to 1.79)
OC No 278 743 1.00 (referent) 0.894
Yes 161 455 1.02 (0.80 to 1.29)
HRT No 364 1022 1.00 (referent) 0.265
Yes 75 173 1.19 (0.88 to 1.62)
SMOKING No 415 1126 1.00 (referent) 0.831
Yes 24 72 1.05 (0.98 to 1.72)
WHR ≤ 0.85 293 863 1.00 (referent) 0.074
> 0.85 146 335 1.25 (0.98 to 1.60)
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http://www.biomedcentral.com/1471-2407/12/529respectively. These predicted rates were compared with
those observed in Figure 1. Thus, for example, GAIL-
SBSP under predicted in the seventh, ninth and tenth
deciles, there were generally closer predictions with S-
GAIL-SBSP except in the sixth decile, and a considerable
over prediction in the tenth decile with E-GAIL-SBSP.
Clearly the addition of BMI and parity to E-GAIL-SBSP
did not materially improve calibration.
The unweighted average concordance statistics were
very similar, and not statistically significantly different,
with AUC = 0.6098 (CI=0.57 to 0.65), 0.5997 (CI=0.56
to 0.64), and 0.6162 (CI=0.58 to 0.65) for GAIL-SBSP, S-
GAIL-SBSP and E-GAIL-SBSP, respectively (Figure 2). Inaddition, the estimated age-specific AUC of S-GAIL-
SBSP for the intervals from 50 to 74 years were modest
except in the oldest group; specifically, 0.5766 (CI=0.53
to 0.62) for those aged 50 - 59, 0.5838 (CI=0.53 to 0.64)
for 60 - 69 years, and 0.8938 (CI=0.70 to 1.00) for 70 -
74 years.
Discussion
Although first developed by MH Gail and his associates
[1] some 25 years ago, the GAIL model continues to play
an important role in predicting the 5-year risk of inva-
sive breast cancer. Thus Schonfeld et al [15] have shown
that GAIL remains well calibrated in more recent
Table 6 Prevalence of breast cancer risk factors in the nested case-control study within Singapore Breast Screening
Programme (SBSP) cohort and relative risks (RR) from SBSP and the Breast Cancer Detection and Demonstration
Project (BCDDP)
Cases Control Total (%) RR
E-GAIL-SBSP S-GAIL-SBSP BCDDP
Women (n) 439 1,198 1,637 1,637 1,637 5,998
AGEMEN (y)
≥14 246 772 1,018 (62.19) 1 1 1
12–13 173 377 550 (33.60) 1.23 1.27 1.10
<12 20 49 69 (4.22) 1.50 1.61 1.21
AGECAT (y) NBIOPS
<50 0 2 10 12 (0.73) – – 1
1 0 1 1 (0.06) – – 1.70
2 – – – – – 2.88
≥50 0 396 1,109 1,505 (91.94) – – 1
1 41 78 119 (7.27) – – 1.27
2 – – – – – 1.62
AGEFLB (y) NUMREL
<20 0 54 182 236 (14.42) 1 1 1
1 2 5 7 (0.43) 2.17 2.17 2.61
≥2 – – – 4.70 4.73 6.80
20–24 0 123 431 554 (33.84) 1.19 1.20 1.24
1 7 11 18 (1.10) 2.57 2.61 2.68
≥2 2 0 2 (0.12) 5.57 5.68 5.78
25–29 or nulliparous 0 172 410 582 (35.55) 1.40 1.44 1.55
1 13 15 28 (1.71) 3.05 3.14 2.76
≥2 – – – 6.60 6.83 4.91
≥30 0 62 139 201 (12.28) 1.66 1.73 1.93
1 3 5 8 (0.49) 3.61 3.77 2.83
≥2 1 0 1 (0.06) 7.82 8.20 4.17
BMI (kg/m2)
< 23.0 126 476 602 (36.82) 1 – –
23.0 – 27.4 207 497 704 (43.06) 1.46 – –
≥ 27.5 106 223 329 (20.12) 2.14 – –
PARITY
≥3 263 801 1,064 (65.00) 1 – –
1–2 112 276 388 (23.70) 1.23 – –
0 64 121 185 (11.30) 1.50 – –
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made, application of the underlying methodology to
non-Caucasian women has been limited and suggests
that further modification may need to be made for its
use in women of other ethnic groups. Singapore has a
population which is predominantly of Chinese ethnicity
but also with those of Malay and Indian descent and has
also completed a large mammographic screening study
involving 29,193 randomly selected women follow-upfrom which enables invasive breast cancer rates to be
determined. Thus the very different breast cancer rates,
and etiological risk factors varying in their presence and
magnitude when compared to other populations, enables
the GAIL model itself to be tested and variants (if rele-
vant) to be established.
Retaining the GAIL model structure, but applying
Singapore national and race-specific invasive breast can-
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Figure 1 Comparison of observed breast cancer risk with that
predicted by each model. The horizontal axis shows the grouping
by deciles of risk and the vertical axis the observed and
corresponding predicted risk.
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http://www.biomedcentral.com/1471-2407/12/529SBSP resulted in absolute risk projections that worked
reasonably well as assessed by the comparison of
observed and expected cases across all age groups and
amongst the majority of risk categories (Tables 3 & 4).
In total 241 cases were recorded while GAIL-SBSP pre-
dicted 241.83 (E/O=1.00, CI=0.88 to 1.14). However, the
model under predicted for the very few women who had
two or more first-degree-relatives with breast cancer.
Prediction was satisfactory for Chinese women but over-
predicted for the Malay and Indian women. Since these
latter groups each comprise of only 5% of the population
studied, the accuracy of these specific predictions
requires further investigation in residents of the Malay-
sian Peninsula and the Indian Sub-Continent. Neverthe-
less, the results for the Chinese women suggests the
potential that GAIL can be improved for South-East
Asian populations by using local (and/or updated) esti-
mates of incidence and competing mortality rates.
Although the performance of GAIL-SBSP is in general
satisfactory, at least amongst Singapore-Chinese women,
one might anticipate that taking into account implica-
tions of the different health systems and etiological fac-
tors may produce improved prediction. For example,
only 10% of the subjects in the SBSP cohort had had a
mammogram in the previous year and this may have an
impact on the apparent natural history of disease. More
generally, women from much of the Asia-Pacific region
do not receive regular mammogram screening [20]. Also,
some factors included in GAIL may have different con-
sequences in an Asian-Pacific population due to genetic
predisposition, geographic, or other influences. To ex-
plore these aspects we initially used the same risk factors
and coding that were in the original model of GAIL [1,2]
to estimate relative risks with subjects from a case-
control study, nested within the SBSP cohort (GAIL-
SBSP (FULL)) and to compare these estimates with
those from the BCDDP Table 2. Finally we derive a sim-
plified model (S-GAIL-SBSP) with fewer risk factors and
also an extended one (E-GAIL-SBSP) with additional
risk factors included both incorporating local baseline
race-specific breast cancer and other mortality rates.
S-GAIL-SBSP, which included age-at-menarche, age-
at-birth of first live child and number of first-degree-
relatives with breast cancer was well calibrated in the
total SBSP cohort and across most subgroups (Tables 3
& 4). It was not surprising that ‘ever having previous be-
nign breast biopsy’ was not included in this revised pre-
diction for Singaporean women as this reflects a specific











0.00 0.25 0.50 0.75 1.00
1-Specificity
GAIL-SBSP     (AUC: 0.6098)
S-GAIL-SBSP  (AUC: 0.5997)
E-GAIL-SBSP  (AUC: 0.6162)
Figure 2 Receiver operating characteristic and corresponding area-under-the-curve (AUC) for the breast cancer risks predicted by
GAIL-SBSP, S-GAIL-SBSP and E-GAIL-SBSP, respectively.
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http://www.biomedcentral.com/1471-2407/12/529common as is the case for the majority of Asian women
(including Chinese-Occidental migrants) [20,21] although
an increasing proportion of these women now receive
mammographic screening [22,23]. Other evidence for the
use of simpler, but more targeted, models has been pro-
vided by predictions of estrogen receptor-positive breast
cancer in postmenopausal women in the USA [24]. How-
ever, the concordance from GAIL-SBSP (AUC = 0.61) is
relatively low. This is similar to previous validation studies
in non-Asian populations which have recorded an AUC
between 0.56 and 0.60 for the GAIL model for Caucasian
women [3], for the modified GAIL (CARE) an average
age-specific AUC of 0.555 in African-American women
[8], and 0.614 in Asian- and Pacific-Islander-American
women [25]. Thus a good model with a higher discrimin-
atory accuracy, in addition to good calibration, is needed
[26]. Unfortunately, given the low relative risks associated
with most established non-modifiable breast cancer risk
factors, it is unlikely that any prediction model will have a
much higher discriminatory accuracy [3,27].
The modest concordance suggests that additional fac-
tors prognostic for outcome may be required. In this re-
spect we found that of BMI and parity were independent
predictors of risk. Thus their inclusion in E-GAIL-SBSP,
with modified AR and RRs derived from the SBSP co-
hort, marginally improved the discriminatory power
(AUC = 0.62) but overestimated the predicted breast
cancer cases substantially in, for example, the highest
decile (Figure 1). One reason for this is that the ARs cal-
culated may be inappropriate, possibly due to the true
risk factor prevalence by age not taking a binary form
with a cut at 50 years and/or influencing Asian womenin different ways. Using the original AR values of GAIL
made no improvement. Also overestimates may be a
consequence of over-fitting a model with many risk fac-
tors based on only a modest number of cases and con-
trols [28]. Similar mixed results were observed when the
use of hormonal replacement therapy, oral contracep-
tion, smoking and waist-to-hip ratio were investigated
(unreported analyses).
It has been suggested that the addition of mammo-
graphic breast density could provide improved discrim-
inatory power for the GAIL model for Caucasian women
[29,30] as the density is associated with an increased risk
of breast cancer [13,31]. Further women with Tabar IV
[32] parenchymal patterns amongst the SBSP cohort also
have a significant higher risk of breast cancer when
compared to those with the remaining patterns (odds
ratio=2.30, CI=1.14 to 4.63). However those screened for
this in the SBSP study were too few in number for us to
validate any model that incorporates this risk factor.
The GAIL-SBSP, S-GAIL-SBSP and E-GAIL-SBSP
models should always be applied with caution or avoided
for certain specific populations as is true for GAIL itself.
For example, although large SBSP was essentially con-
fined (95%) to those of 50 and more years, they are ap-
plicable to younger women but further validation is
needed. Further, we started the “clock” three years after
negative screening which implies the SBSP based models
are pertinent to women thought to be free of breast can-
cer. A woman who has just had a negative breast exam-
ination and mammogram, as the United Kingdom breast
screening programme has shown, has about one third
the absolute risk of breast cancer in the following three
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http://www.biomedcentral.com/1471-2407/12/529years [33]. Nevertheless, to establish the risks defini-
tively, validation studies from a more representative
sample of South-East Asian women in regular follow-up
are required.
The strengths of this study include the use of a pre-
dominately postmenopausal group of women from three
ethnic groups, Chinese, Malay and Indian, drawn from a
very large screening program in which more than 29,000
women were randomly chosen to participate. Further,
since neither Asian- or Chinese-Occidental (born in or
migrated to the West) women were systematically
included in the development of the Gail-based models
[1,2]. We believe this is the first attempt to validate and
modify the basic GAIL model to ethnically diverse
women living in an Asian region. Earlier studies [21]
have explored those of Chinese-Occidental origin who
had migrated when aged less than 21 years (N=216) or
had been residents in a western country for 10 years or
less (N=421) [21] and Asian- and Pacific-Islander-
American women [25].
Limitations of using SBSP data for individual absolute
risk predictions include the inability of the nested case-
control study to estimate elaborate models with suffi-
cient precision. Also our validation data included rela-
tively small numbers of breast cancer cases, especially
amongst Singapore-Malay and -Indian women and those
with two or more affected first-degree relatives. Further-
more, as with retrospective studies in general, the level
of ascertainment of incident cases is of concern. How-
ever, Singapore is a small island where all citizens and
permanent residents are registered in the population
registry with a unique registration number. Also cancer
notification is mandatory and this enables near complete
ascertainment of breast cancer incidence by linkage of
SBSP participants with the Singapore Cancer Register
database.Conclusion
In conclusion, we found that among South-East Asian
postmenopausal women, the GAIL type model could be
refined using race-specific estimates of invasive breast
cancer incidence and other cause mortality rates. A
model which includes age-at-menarche, age-at-birth of
first live child and number of first-degree-relatives with
breast cancer appears to provide a simpler approach for
projecting absolute risk of invasive breast cancer in
South-East Asia women. Nevertheless its role in coun-
seling the individual women regarding their risk of
breast cancer remains problematical and needs to be
validated in independent data.Competing interests
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